Abstract
In the United States, community-acquired pneumonia (CAP) in adults results in approximately 600,000 hospital admissions annually and ranks as the sixth leading cause of death. Of those patients with CAP hospitalized, between 18% and 36% require treatment in an ICU. The mortality of these patients is about 35%. While approximately 20% of patients admitted to the ICU with CAP are in septic shock, the mortality of these patients may be as high as 60%.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Selected References
Bartlett JG, Breiman BR, Mandell LA, File TM. Community-acquired pneumonia in adults: Guidelines for management. Clin Infect Dis. 1998;26: 811–838.
Davies RJ, Traill ZC, Gleeson FV. Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection. Thorax. 1997;52:416–421.
Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity and initial antimicrobial therapy. Am Rev Respir Dis. 1993;148:1418–1426.
Harwell JI, Brown RB. The drug-resistant pneumococcus. Clinical relevance, therapy and prevention. Chest. 2000;117:530–541.
Henke CA, Leatherman JW. Intrapleurally administered streptokinase in the treatment of acute loculated nonpurulent parapneumonic effusions. Am Rev Respir Dis. 1992;145:680–684.
Leroy O, Santre C, Beuscart C, et al. A five-year study of severe community-acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intensive Care Med. 1995;21:24–31.
Leroy O, Vandenbussche C, Coffinier C, et al. Community-acquired aspiration pneumonia in intensive care units. Epidemiological and prognosis data. Am J Respir Crit Care Med. 1997;156:1922–1929.
Moine P, Vercken JB, Chevret S, Gajdos P. Severe community-acquired pneumococcal pneumonia. The French Study Group of Community- Acquired Pneumonia in ICU. Scand J Infect Dis. 1995;27:201–206.
Niederman MS. Severe community-acquired pneumonia: what do we need to know to effectively manage patients? Intensive Care Med. 1996;22: 1285–1287.
Rudin ML, Michael JR, Huxley EJ. Community-acquired acinetobacter pneumonia. Am J Med. 1979;67:39–43.
Thornsberry C, Hickey ML, Kahn J, Mauritz Y, Sahm DE Surveillance of antimicrobial resistance among respiratory tract pathogens in the United States, 1997 to 1998. Drugs. 1999;58(suppl 2):361–363.
Torres A, Serra-Bataille J, Ferrer A et al. Severe community-acquired pneumonia epidemiology and prognostic factors. Am Rev Respir Dis. 1991;144: 312–318.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag New York, Inc.
About this chapter
Cite this chapter
Marik, P.E. (2001). Severe Community- Acquired Pneumonia. In: Handbook of Evidence-Based Critical Care. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-86943-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-86943-3_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78093-9
Online ISBN: 978-3-642-86943-3
eBook Packages: Springer Book Archive